Lyell Immunopharma raised $175m in Series A financing led by BMGI Group.

Synopsis

Lyell Immunopharma, a biotechnology company in South San Francisco, raised $175m in Series A financing led by BMGI Group.

Principals

Lyell Immunopharma

Bmgi Group

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

latham & watkins

HQ - New York, United States

legal advisors

bidder

5558

Deals

£ 3,639.15 B

Total Value

fenwick & west

HQ - Silicon Valley

legal advisors

target

403

Deals

£ 243.75 B

Total Value